about
Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study.Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.ptGenetic Predictors of Poor Prognosis in Portuguese Patients with Juvenile Idiopathic Arthritis: Data from Reuma.pt.Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt.Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration.[Inflammatory myopathy with an unusual evolution].[Portuguese recommendations for the use of methotrexate in the treatment of rheumatoid arthritis].A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities[Portuguese recommendations on "How to diagnose, monitor, and treat undifferentiated peripheral arthritis": systematic review of the literature and the experts' opinion].Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus.Association of systemic lupus erythematosus clinical features with European population genetic substructure.Acute acalculous cholecystitis in a patient with juvenile dermatomyositisEarly vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk.Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only studyAnti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile.Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients.Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients.Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: a case-control study.Real-life effectiveness of Golimumab in biologic-naïve patients with rheumatoid arthritis - data from the Rheumatic Diseases Portuguese Register (Reuma.pt).Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study.Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damage.Interleukin-6 as a key player in systemic inflammation and joint destruction.Methotrexate treatment in rheumatoid arthritis: management in clinical remission, common infection and tuberculosis. Results from a systematic literature review.Home-Based Intervention Program to Reduce Food Insecurity in Elderly Populations Using a TV App: Study Protocol of the Randomized Controlled Trial Saúde.Come Senior.Metabolic syndrome, inflammation and atherosclerosis - the role of adipokines in health and in systemic inflammatory rheumatic diseases.Portuguese recommendations for the diagnosis and management of gout.Prognostic value of antinuclear antibodies in juvenile idiopathic arthritis and anterior uveitis. Results from a systematic literature review.Incidence and predictors of cardiovascular events in a cohort of patients with rheumatoid arthritis.Management of infections in rheumatic patients receiving biological therapies. The Portuguese Society of Rheumatology recommendations.Applicability of the EULAR recommendations on the role of the nurse in the management of chronic inflammatory arthritis in Portugal.Neural cell adhesion molecule is expressed by smooth muscle cells during the development of the rat vascular system.[Rheumatic expression of secondary syphilis].Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients.Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.Tumor necrosis factor-alpha -308 genotypes influence inflammatory activity and TNF-alpha serum concentrations in children with juvenile idiopathic arthritis.Systemic rheumatic diseases: beyond classification criteria.Predictors of response and anti-TNF drugs comparative efficacy.Active regulatory T-cells contribute to broadened T-cell repertoire diversity in ivIg-treated SLE patients.
P50
Q30488972-E7227C7B-842C-479E-9612-E42D617C8CD4Q30956564-225B215C-284D-49F4-A241-21F2044D66C4Q31011687-831876B2-AD4B-40A2-950D-FB270584D5F0Q31032345-4F9ECFEF-1340-42B8-A3E2-85021C87D7A6Q31058821-86A115BF-CC97-4923-B209-475C23680AF2Q31154802-3F772DC6-A7AE-49EF-9E2D-35613D29B2B9Q33391409-C7EEBA5E-F6AF-45F8-B494-458943189F71Q33431818-B946510D-7449-41D4-9428-E063EE1D0B28Q33576975-1D6A20A2-E075-4BB7-9541-07AF532369C5Q33796431-75385EA7-CC23-4E56-81D9-0BBF69FD006BQ33892741-29FCE234-C607-4944-B72E-B873EC2F5F21Q34110676-CB3FA22E-F0D0-43C2-9371-2DD2884E564EQ34220104-91A36601-93EF-434E-9370-382E506E4AB4Q34409903-C945F8B2-30CD-4A96-97AB-F4F6BC6E222FQ34438072-8118781A-C4E6-4182-B8E1-9D1CB48C76F0Q34655140-5FDDB71E-A872-4091-9AB9-CB7694172D06Q34977573-B00F32D5-CAF4-4D57-8FA3-1192B56D0782Q35840828-7708C8B5-E3F4-445B-9982-87A4ABEC9BE0Q36245885-465DE7CA-46CA-4C5C-B41F-0C690C5E0518Q36332887-49B687C0-55C8-40E6-A095-26CF0101113AQ37309669-ED28EA7A-B9A3-4039-BC19-817F501505EFQ37312650-E119378E-3C89-40C9-B1AF-44819C07150FQ37384484-58E75240-FD58-43A1-B19A-71392A23AD19Q37689022-BCE37DCC-1D5A-4D63-B8FB-8E63C9517C4FQ37723650-848E3B07-8EF2-423A-8824-03CD87E743F0Q37790264-4496A86B-B80E-4B6F-95A4-E0C39A3610A0Q38213657-D65BEA29-FBA6-4E23-B752-BC3F4612858DQ38216261-E9DF0267-9ABF-4AC5-A2E7-458DDB6435C7Q38806324-4D246698-4104-4322-9E34-BF9A2FD866B2Q38966752-80984268-13C3-43B9-8B2D-DEA626E9804FQ39327992-8395F0E6-F148-40EF-A3E4-2A6043AB3932Q42496370-043BAB42-F24A-4B85-84A3-4091DEBA08A5Q43407863-1D9CEC1E-4E0B-4E5F-91E2-18D915867861Q43667787-131FAA70-E138-4696-ADAE-40564D926D03Q43736626-3097DA8E-E239-4797-81FE-F84666C0053DQ44618828-BC20777B-0D16-4EDD-B1A3-E0CEB96676B4Q45394763-C91D8F71-180B-4F81-A3F8-DA657988C008Q46015832-8224F167-4F29-47C9-877C-B5C32B7362FFQ46090249-5ADD8791-8242-4EDD-A0D9-312451C289B8Q46090296-771D9F0C-E84C-49EE-BEB1-3AB4DD5FC098
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0002-7946-1365
@en
name
Maria J Santos
@es
Maria J Santos
@nl
Maria J Santos
@sl
Maria J. Santos
@en
type
label
Maria J Santos
@es
Maria J Santos
@nl
Maria J Santos
@sl
Maria J. Santos
@en
prefLabel
Maria J Santos
@es
Maria J Santos
@nl
Maria J Santos
@sl
Maria J. Santos
@en
P106
P1153
57031119100
6504832495
P21
P31
P496
0000-0002-7946-1365